Actua Corp. (ACTA) Tops Q3 EPS by 5c, Updates FY15 Guidance

Actua Corp. (NASDAQ: ACTA) reported Q3 EPS of ($0.07), $0.05 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $34.1 million versus the consensus estimate of $33.88 million.

Actua Corp. sees FY2015 EPS of ($0.33)-($0.36), versus prior guidance of ($0.36)-($0.40) and the consensus of ($0.38). Actua Corp. sees FY2015 revenue of $133-134 million, versus prior guidance of $133-138 million and the consensus of $135.5 million.

For earnings history and earnings-related data on Actua Corp. (ACTA) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance